SCHEMBL6977094

SCHEMBL6977094

O=c1cc(-c2ccccc2N2CCOCC2)nc(S)[nH]1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 1/20 0.45
CDC7 O00311 1/20 0.45
DBF4 Q9UBU7 1/20 0.45
MEN1 O00255 1/20 0.45
NPC1 O15118 1/20 0.45
MAPT P10636 1/20 0.45
RAB9A P51151 1/20 0.45
KMT2A Q03164 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
AKT1 P31749 13/20 0.45
PIK3CA P42336 8/20 0.45
PIK3CB P42338 8/20 0.45
PIK3CD O00329 6/20 0.45
PIK3CG P48736 6/20 0.45
CYP3A4 P08684 5/20 0.45
PIK3C3 Q8NEB9 2/20 0.45
PIK3C2G O75747 1/20 0.45
PRKDC P78527 1/20 0.45
NRP1 O14786 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6977099 0.78 XDH (0.72) XDHMEN1NPC1MAPTRAB9A
SCHEMBL13537211 0.68 HTR7 (0.68) MEN1NPC1MAPTRAB9AKMT2A
SCHEMBL12270084 0.68 BRD9 (0.49) MEN1NPC1MAPTRAB9AKMT2A
SCHEMBL27930339 0.66 CDK2 (0.58) MEN1NPC1MAPTRAB9AKMT2A
SCHEMBL824947 0.66 TDO2 (0.51) MEN1NPC1MAPTRAB9AKMT2A
SCHEMBL14983924 0.66 MAPT (0.69) MEN1NPC1MAPTRAB9AKMT2A
SCHEMBL9424119 0.65 LMNA (0.62) MEN1NPC1MAPTRAB9AKMT2A
SCHEMBL15362290 0.65 HTR7 (0.62) MEN1NPC1MAPTRAB9AKMT2A
SCHEMBL824716 0.65 APAF1 (0.49) MEN1NPC1MAPTRAB9AKMT2A
SCHEMBL824701 0.65 APAF1 (0.49) MEN1NPC1MAPTRAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1109560-B1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMA (US) 2003-08-27 EP disclosed
US-6525050-B1 Inhibit the enzyme aminoimidazole carboxamide ribonucleotide formyl transferase; antiproliferative agents; antitumor, antiinflammatory, antipsoriatic, and/or immunosuppressive AGOURON PHARMACEUTICALS, INC. 2003-02-25 US disclosed
EP-1109560-A4 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMA (US) 2002-04-17 EP disclosed
EP-1109560-A1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 2001-06-27 EP disclosed
WO-2000013688-A1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 2000-03-16 WO disclosed